Moreover, our previous study investigating the role of PARK7/DJ-1 in DSS-induced colitis also demonstrated that pharmacological activation of PARK7/DJ-1 resulted in the decreased expression of pro-inflammatory cytokines, including IL-1β and IL-6, and decreased diseases activity index in the DSS treated mice [11]. This evidence concerns the gene PARK7 and colitis.